Company intelligence / Profile preview

Peak Proteins

Macclesfield, England, United Kingdompeakproteins.com ↗

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Peak Proteins is a contract research organisation specializing in custom-made soluble and membrane proteins for use in drug discovery and research. They provide expert services including protein expression, purification, characterization, X-ray crystallography, NMR spectroscopy, Cryo-Electron Microscopy (CryoEM), and mass spectrometry. The company was acquired by Sygnature Discovery in April 2022 but continues to operate as an integrated part of the group.

Modalities: ProteinRecombinant proteinBiologic
Industry: Drug Discovery Services

Partnerships

Sygnature Discovery (integration partner)Various pharmaceutical/biotech clients globally

Beyond the preview

Go deeper on Peak Proteins.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peak Proteins.

Explore the full profile